CPG
UTHR icon

Cornerstone Planning Group’s United Therapeutics UTHR Stock Holding History

Cornerstone Planning Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69K Hold
7
– – ﹤0.01% 1172
2026
Q1 		$4.01K Buy
7
+4
+133% +$1.99K ﹤0.01% 1143
2025
Q4 		$1.4K Sell
3
-25
-89% -$11.6K ﹤0.01% 1266
2025
Q3 		$1.37K Buy
28
+25
+833% +$8.41K ﹤0.01% 1239
2025
Q2 		$914 Sell
3
-1
-25% -$299 ﹤0.01% 1136
2025
Q1 		$1.17K Buy
4
+3
+300% +$1.03K ﹤0.01% 1097
2024
Q4 		$370 Buy
+1
New +$368 ﹤0.01% 1222

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cornerstone Planning Group's UTHR Position: Q2 2026 in Review

Cornerstone Planning Group held its United Therapeutics (UTHR) position steady in Q2 2026 at 7 shares worth $3.69K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Cornerstone Planning Group first reported a position in UTHR in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.01K in Q1 2026. 450 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Cornerstone Planning Group held 7 shares of United Therapeutics worth $3.69K as of Q2 2026.
  • Cornerstone Planning Group left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #1172 holding.
  • Cornerstone Planning Group first reported a position in United Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Cornerstone Planning Group's United Therapeutics position peaked at $4.01K in Q1 2026.
  • 450 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.